[Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]
Identifieur interne : 000050 ( PubMed/Corpus ); précédent : 000049; suivant : 000051[Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]
Auteurs : B. Ye ; C. Fan ; Y. Pan ; R. Ding ; H X Hu ; M L XiangSource :
- Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery [ 1673-0860 ] ; 2020.
Abstract
Coronavirus disease 2019 (COVID-19) is raging in China, especially in Hubei Province, which has resulted great dangers in people's life and national economy. According to the guidelines drafted by China's Center for Disease prevention and Control (CDC), the positive nucleic acid test is need to the diagnosis of patient with COVID-19. Upper respiratory tract specimens are the main sources for nucleic acid detection. However, based on international guidelines of COVID-19 , no recommended level of upper respiratory tract sampling method is proposed. Therefore, which kind of sampling methods should be chosen to help the COVID-19 diagnosis and which way is the most secure for doctors and nurses is our concern. In this review, we analyzed a total of 10 literatures on the sampling methods of upper respiratory tract related to infectious diseases such as severe acute respiratory syndrome coronavirus (SARS), middle east respiratory syndrome coronavirus (MERS), and influenza A (H1N1), which were spread worldwide in past years. Literatures were collected from the three dimensions of sampling method, sampling time, and sampling safety. It was found that among all the upper respiratory sampling methods, nasopharyngeal aspirate (NPA) had a higher positive rate within 2 weeks of symptom onset, while combined nasal and oropharyngeal swabs (NS + OPS) was the least harmful to medical staff during sampling. We wish this review is helpful for the prevention of COVID-19.
DOI: 10.3760/cma.j.cn115330-20200223-00116
PubMed: 32166939
Links to Exploration step
pubmed:32166939Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]</title><author><name sortKey="Ye, B" sort="Ye, B" uniqKey="Ye B" first="B" last="Ye">B. Ye</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author><author><name sortKey="Fan, C" sort="Fan, C" uniqKey="Fan C" first="C" last="Fan">C. Fan</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author><author><name sortKey="Pan, Y" sort="Pan, Y" uniqKey="Pan Y" first="Y" last="Pan">Y. Pan</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author><author><name sortKey="Ding, R" sort="Ding, R" uniqKey="Ding R" first="R" last="Ding">R. Ding</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author><author><name sortKey="Hu, H X" sort="Hu, H X" uniqKey="Hu H" first="H X" last="Hu">H X Hu</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author><author><name sortKey="Xiang, M L" sort="Xiang, M L" uniqKey="Xiang M" first="M L" last="Xiang">M L Xiang</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32166939</idno><idno type="pmid">32166939</idno><idno type="doi">10.3760/cma.j.cn115330-20200223-00116</idno><idno type="wicri:Area/PubMed/Corpus">000050</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000050</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]</title><author><name sortKey="Ye, B" sort="Ye, B" uniqKey="Ye B" first="B" last="Ye">B. Ye</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author><author><name sortKey="Fan, C" sort="Fan, C" uniqKey="Fan C" first="C" last="Fan">C. Fan</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author><author><name sortKey="Pan, Y" sort="Pan, Y" uniqKey="Pan Y" first="Y" last="Pan">Y. Pan</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author><author><name sortKey="Ding, R" sort="Ding, R" uniqKey="Ding R" first="R" last="Ding">R. Ding</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author><author><name sortKey="Hu, H X" sort="Hu, H X" uniqKey="Hu H" first="H X" last="Hu">H X Hu</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author><author><name sortKey="Xiang, M L" sort="Xiang, M L" uniqKey="Xiang M" first="M L" last="Xiang">M L Xiang</name><affiliation><nlm:affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery</title><idno type="ISSN">1673-0860</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Coronavirus disease 2019 (COVID-19) is raging in China, especially in Hubei Province, which has resulted great dangers in people's life and national economy. According to the guidelines drafted by China's Center for Disease prevention and Control (CDC), the positive nucleic acid test is need to the diagnosis of patient with COVID-19. Upper respiratory tract specimens are the main sources for nucleic acid detection. However, based on international guidelines of COVID-19 , no recommended level of upper respiratory tract sampling method is proposed. Therefore, which kind of sampling methods should be chosen to help the COVID-19 diagnosis and which way is the most secure for doctors and nurses is our concern. In this review, we analyzed a total of 10 literatures on the sampling methods of upper respiratory tract related to infectious diseases such as severe acute respiratory syndrome coronavirus (SARS), middle east respiratory syndrome coronavirus (MERS), and influenza A (H1N1), which were spread worldwide in past years. Literatures were collected from the three dimensions of sampling method, sampling time, and sampling safety. It was found that among all the upper respiratory sampling methods, nasopharyngeal aspirate (NPA) had a higher positive rate within 2 weeks of symptom onset, while combined nasal and oropharyngeal swabs (NS + OPS) was the least harmful to medical staff during sampling. We wish this review is helpful for the prevention of COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32166939</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1673-0860</ISSN><JournalIssue CitedMedium="Print"><Volume>55</Volume><Issue>0</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery</Title><ISOAbbreviation>Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]</ArticleTitle><Pagination><MedlinePgn>E003</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn115330-20200223-00116</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) is raging in China, especially in Hubei Province, which has resulted great dangers in people's life and national economy. According to the guidelines drafted by China's Center for Disease prevention and Control (CDC), the positive nucleic acid test is need to the diagnosis of patient with COVID-19. Upper respiratory tract specimens are the main sources for nucleic acid detection. However, based on international guidelines of COVID-19 , no recommended level of upper respiratory tract sampling method is proposed. Therefore, which kind of sampling methods should be chosen to help the COVID-19 diagnosis and which way is the most secure for doctors and nurses is our concern. In this review, we analyzed a total of 10 literatures on the sampling methods of upper respiratory tract related to infectious diseases such as severe acute respiratory syndrome coronavirus (SARS), middle east respiratory syndrome coronavirus (MERS), and influenza A (H1N1), which were spread worldwide in past years. Literatures were collected from the three dimensions of sampling method, sampling time, and sampling safety. It was found that among all the upper respiratory sampling methods, nasopharyngeal aspirate (NPA) had a higher positive rate within 2 weeks of symptom onset, while combined nasal and oropharyngeal swabs (NS + OPS) was the least harmful to medical staff during sampling. We wish this review is helpful for the prevention of COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>H X</ForeName><Initials>HX</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>91949119</GrantID><Agency>Training Program of Major Research Plan of National Natural Science Foundation of China</Agency><Country></Country></Grant><Grant><GrantID>81670926</GrantID><Agency>National Natural Science Foundation of China</Agency><Country></Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi</MedlineTA><NlmUniqueID>101247574</NlmUniqueID><ISSNLinking>1673-0860</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="chi"><AbstractText>新型冠状病毒肺炎正在中国肆虐，特别是在湖北武汉，对人民生命健康和经济造成了极大的损失。根据中国疾病预防控制中心（Chinese Center for Disease Control and Prevention，CDC）指南，新型冠状病毒肺炎患者的确诊及治愈均需核酸检测结果确认。上呼吸道取样方法是核酸检测的主要样本来源，但在各国CDC发布的指南中只提出了上呼吸道取样方法，并未提出推荐级别。因此，患者就诊时该选择怎样的取样方法、何种取样方法医护人员的安全性最高成为我们关注的问题。本文对近年来世界范围内流行的严重急性呼吸综合征（SARS）、中东呼吸综合征（MERS）、甲型H1N1流感等传染性疾病相关上呼吸道取样方法研究共10篇文献进行了综述。从取样方法、取样时间、医护人员安全性3个维度整理了收集的文献，发现在所有上呼吸道取样方法中，鼻咽抽取物（NPA）在发病2周内具有较高的阳性率，鼻腔+口咽联合拭子（NS+OPS）对取样操作的医务人员危害最小。期望本综述能对此次疫情的防控提供一些参考。.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Nasopharynx aspirate</Keyword><Keyword MajorTopicYN="N">Nucleic acid detection</Keyword><Keyword MajorTopicYN="N">Sampling method</Keyword><Keyword MajorTopicYN="N">Upper respiratory tract</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32166939</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn115330-20200223-00116</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000050 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000050 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:32166939
|texte= [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?]
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:32166939" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidV1
| This area was generated with Dilib version V0.6.33. |  |